Entry Point Capital, LLC Glaukos Corp Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
A detailed history of Entry Point Capital, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Entry Point Capital, LLC holds 75 shares of GKOS stock, worth $10,401. This represents 0.01% of its overall portfolio holdings.
Number of Shares
75Holding current value
$10,401% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding GKOS
# of Institutions
307Shares Held
46.8MCall Options Held
75.3KPut Options Held
157K-
Black Rock Inc. New York, NY8.04MShares$1.11 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.45MShares$756 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD1.9MShares$263 Million4.61% of portfolio
-
State Street Corp Boston, MA1.86MShares$257 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.61MShares$224 Million0.04% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $6.6B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...